Two-day symposium in Riyadh, Saudi Arabia brings together leading oncology professionals from across the MENA region to review updated treatment recommendations. RIYADH, Saudi Arabia, Jan.
Shares of Immuneering Corporation (NASDAQ:IMRX) surged 55% following the release of encouraging data from its ongoing Phase 2a trial of IMM-1-104, a therapy for pancreatic cancer. The Cambridge-based ...
More than 10 thousand cancer treatments have been successfully completed here so far. Thangam Cancer Treatment Center is making many achievements not only in cancer treatment but also in lung surgery.